The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications

Neurosurgery

Volumn 74, Issue 1, 2014, Pages 9-15

  Sharpton, Suzanne R ^a   Oermann, Eric K ^b   Moore, Dominic T ^c   Schreiber, Eric ^b   Hoffman, Riane ^b   Morris, David E ^b   Ewend, Matthew G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

Author keywords

Brain metastases; Local control; Radiosurgery; Volumetric response

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CORTICOSTEROID THERAPY; CYBERKNIFE; DISEASE COURSE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY ELDERLY; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84891827398     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000190     Document Type: Article

References (20)

1. Patchell RA. The management of brain metastases. Cancer Treat Rev. 2003;29(6): 533-540.
2. Smedby KE, Brandt L, Bäcklund ML, Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer. 2009;101(11):1919-1924.
3. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus wholebrain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483-2491.
4. Rades D, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer. 2007;110(10):2285-2292.
5. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53(3):519-526.
6. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL. Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery. 2008;62(suppl 2):790-801.
7. Chang EL, Selek U, Hassenbusch SJ III, et al. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005;56(5):936-945; discussion 936-945.
8. Hara W, Tran P, Li G, et al. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Neurosurgery. 2009;64(2 suppl):A26-A32.
9. Da Silva AN, Nagayama K, Schlesinger D, Sheehan JP. Early brain tumor metastasis reduction following Gamma Knife surgery. J Neurosurg. 2009;110(3): 547-552.
10. Feigl GC, Horstmann GA. Volumetric follow up of brain metastases: a useful method to evaluate treatment outcome and predict survival after Gamma Knife surgery? J Neurosurg. 2006;105(suppl):91-98.
11. Kim WH, Kim DG, Han JH, et al. Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival. Int J Radiat Oncol Biol Phys. 2012;82(5)1749-1755.
12. Zada G, Yu C, Pagnini PG, Khalessi AA, Zelman V, Apuzzo ML. Early decreased tumor volume following fractionated Gamma Knife Radiosurgery for metastatic melanoma and the role of "adaptive radiosurgery": case report. Neurosurgery. 2010; 67(2):E512-E513.
13. Liew DN, Kano H, Kondziolka D, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg. 2011;114(3): 769-779.
14. Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JP, Chiang VL. A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol. 2011;32(10):1885-1892.
15. Yang HC, Kano H, Lunsford LD, Niranjan A, Flickinger JC, Kondziolka D. What factors predict the response of larger brain metastases to radiosurgery? Neurosurgery. 2011;68(3):682-690; discussion 690.
16. Kass RE, Raftery AE. Bayes factors. J Am Stat Assoc. 1995;90(430):773- 795.
17. Raftery AE. Bayesian model selection in social research. Sociological Methodol. 1995;25(5):111-163.
18. Linskey ME, Andrews DW, Asher AL, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96 (1):45-68.
19. Provenzale JM, Ison C, Delong D. Bidimensional measurements in brain tumors: assessment of interobserver variability. AJR Am J Roentgenol. 2009;193(6):W515- W522.
20. Bauknecht HC, Romano VC, Rogalla P, et al. Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrastenhanced magnetic resonance imaging. Invest Radiol. 2010;45(1):49-56.